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SEASONAL CHANGES AND SERUM 25(OH)D LEVELS AMONG 
 COMMUNITY−DWELLING ELDERS WHO LIVE IN BOSTON,  
MASSACHUSETTS AND STOCKHOLM, SWEDEN 
 
KUANG-WEI CHANG  
ABSTRACT 	 Background: The prevalence of Vitamin D deficiency is roughly 40% in the 
world and is increasing every year. Populations 65 years and older show a higher 
prevalence of vitamin D deficiency, because the aging process decreases the capacity of 
the skin to produce vitamin D. Some studies have reported that the prevalence of vitamin 
D deficiency is higher in the winter, however the effect of seasonal change on serum 
vitamin D level remains controversial in some specific populations. Moreover, this 
association remains uncertain in the elderly population because there is no study that 
specifically targets individuals over the age of 65. This study investigated the effect of 
seasonal changes and serum 25-hydroxyvitamin D among individuals 65 years and older 
residing in the Boston, Massachusetts and Stockholm, Sweden.  
 	 Methods: Cross-sectional and longitudinal cohort designs were both adapted to 
examine an existing data from VIVE2 parent study; the data was collected from 2012 to 
2014.  Data from the subjects who had finished this 6-month trial were analyzed for this 
study. Serum 25(OH)D levels, BMI, sex, study sites and age were collected and analyzed 
by univariate regression analysis and t-test. Serum 25(OH)D and confounders were 
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included in multivariate analysis. Study sites were analyzed by effect modification 
model.  
 	 Results: In total, the prevalence of vitamin D deficiency (serum 25(OH)D levels 
less than 20 ng/ml) was 70%, while the mean serum 25(OH)D level was 20 ng/ml in 
summer and 16.4 ng/ml in winter. The average of seasonal serum 25(OH)D level changes 
were 6 ng/ml and 3 ng/ml in Stockholm, Sweden and Boston, MA, respectively. In 
addition, the prevalence of vitamin D deficiency increased 80% during winter (95CI: 1.1 
– 2.9). There was no significant different in serum 25(OH)D levels among elderly 
populations between low latitude study site Boston, MA and high latitude site Stockholm, 
Sweden. There was no significant relation found in BMI, age and sex with serum 
25(OH)D levels in the study. The seasonal serum 25(OH)D level changes was 
significantly different in the cross-sectional study design but not in the longitudinal study.  
 	 Conclusion: Serum 25(OH)D levels were higher in the summer than in the winter 
among the elderly population resided in Boston, MA and Stockholm, Sweden.  
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INTRODUCTION 
 
Vitamin D 
 Vitamin D is a group of fat soluble seco-steroids that exist in two major forms; 
vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol).1,2 Vitamin D was first 
identified as a vitamin by McCollum in the early 20th century. He discovered an unknown 
nutrient in cod liver oil that could heal rickets, thereafter named vitamin D.3 Currently,  
vitamin D is considered a pro-hormone because the biologically active form of vitamin 
D, 1,25-dihydroxyvitamin D (calcitriol) is actually a steroid hormone which functions in 
similar ways as other steroid hormones.2–4 Vitamin D is also known as the “sunshine 
vitamin” as it is synthesized from exposure to the UVB (Ultraviolet B) radiation from sun 
light or artificial UV lights.1–6 
 As noted previously, vitamin D exists in two primary forms; vitamin D3 and 
vitamin D2. Vitamin D3, also known as cholecalciferol. Humans have the ability to 
synthesize vitamin D3 by exposure of the skin to sunlight.1,3,4,6–8 The diet is the other 
source from which vitamin D3 can be obtained. The consumption of vitamin D rich foods 
such as polar bear’s livers and most oil-rich fish (cod, salmon and herring) improves 
serum 25(OH)D levels and maintains bone health, especially Eskimo population.1,6 In 
addition, most foods are now fortified with vitamin D3. 
 Vitamin D2, ergocalciferol, is another typical type of vitamin D. Vitamin D2 is 
transformed from sterol ergosterol, and is naturally found in most sun exposed 
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mushrooms and yeasts.1,3,6,9 Even though human beings are not able to make vitamin D2, 
supplements and pharmaceutical forms of vitamin D2 are typically available.2,6,9,10  
Vitamin D2 and D3 only differ in their side chain structure.2 In low-to-normal 
doses (≤ 1000 IU), vitamin D2 responds similarly in the human body and exhibits the 
same potency to treat rickets and vitamin D deficiency as vitamin D3.2,11 However, some 
studies reported that vitamin D3 is more efficient than vitamin D2 to maintain serum 
25(OH)D level in intermittent high dose therapy (50,000 IU). This result may be 
explained by the different storage amount of vitamin D3 and vitamin D2 in the human 
body. In general, a portion of vitamin D3 will be stored in the fatty tissue after 
photosynthesis of vitamin D3 in human epidermal cells, and these vitamin D3 will be 
released from fatty tissue to maintain serum vitamin D3 status while serum vitamin D3 
level is getting low.12 On the other hand, serum vitamin D2 reached plateau then came 
back to baseline because there was no vitamin D2 stored in human body fat to sustain 
serum vitamin D2 concertation. Therefore, vitamin D3 was seem to maintain serum 
vitamin D concentration longer comparing to vitamin D2 in the intermittent high dose 
therapy. Actually, it has been reported that vitamin D2 and vitamin D3 are equally 
efficacious in their respective abilities to raise serum 25(OH)D concentrations.13 Overall, 
both vitamin D2 and D3 can be used in supplement products or added to vitamin D 
fortified food to improve vitamin D status.2,6,9,14 
 Scientists have acknowledged that vitamin D is an important component for 
maintaining skeleton metabolism, the concentration of calcium, phosphate metabolism 
and immune functions.1,3,6,15 Further, adequate sunlight exposure or vitamin D 
	3 
supplementation is necessary for children in the prevention and treatment of rickets and 
osteomalacia.3,9,15 Current research reports that vitamin D receptors (VDR) could be 
found in almost every tissue, demonstrating that vitamin D may play an important role in 
preventing or improving diseases such as diabetes mellitus, rheumatoid arthritis, 
schizophrenia, multiple sclerosis, colorectal cancer, cardiovascular event, chronic 
diseases, influenza and fractures.1–4,6–9,14–21 Therefore, awareness of maintaining normal 
levels of serum vitamin D is important for preserving quality life, not only in children but 
for all populations.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Nutritional forms of Vitamin D.3 
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Vitamin D photosynthesis and metabolism 
 UVB radiation is absorbed by protein, DNA, RNA as well as 7-
dehydrocholesterol (7-DHC / pro-vitamin D3), all which exist in the epidermal cells, 
when human skin is exposed to sunlight or artificial UVB light (with wavelengths 
between 290−315 nm).1–3,6,7,15,19,22–24 The absorption of UVB radiation stimulates the 
photolysis of 7-dehydrocholesterol to form previtamin D3; a process which occurs in the 
cell membrane of living epidermal cells.1,3,22,25–27 Then, previtamin D3 will undergo the 
thermodynamic reaction, resulting in the rearrangement of double bonds to form vitamin 
D3.2,3,15,19,23–26,28,29  
There are two conformeric forms of pre-vitamin D3 observed in in-vitro testing: s-
trans, s-cis-pre-vitamin D3 (czt), and s-cis, s-cis-pre-vitamin D3 (czc).1,25,28,30,31 The czt 
conformer is very thermodynamically steady and is unable to form vitamin D3.1,23,25 
Conversely, vitamin D3 will be isomerized from czc conformer because it is much less 
thermodynamically stable (than the czt conformer).1,3 However, 7-dehydrocholesterol in 
epidermal cells are mainly located in the cell membrane, inserted between the 
phospholipids.1,19,23,28,32 The inserted structure of 7-dehydrocholesterol could be only 
isomerized to the czc form of pre-vitamin D3 after exposure to UVB.1,3 Hereafter, the czc 
conformer rapidly transforms to vitamin D3. As a result, the human skin is able to process 
this reaction and complete vitamin D photosynthesis in roughly 8 hours after sun 
exposure.1,3,30 After vitamin D is produced, the cell membrane releases vitamin D 
because it is very thermodynamically stable and flexible.1,23,28 Vitamin D will then 
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diffuse into the capillaries and bind with the vitamin D binding proteins (DBP).23–
25,27,29,31,33  
 Vitamin D from skin photosynthesis or diet enters the circulation and binds with 
DBP. The compound of vitamin D and DBP is then transported to the liver via the blood 
circulation.22,23,25 Once in the liver, vitamin D is hydroxylated on the position of carbon 
25 (C-25) by vitamin D-25-hydroxylases (25-OHase) to form 25-hydroxyvitamin D 
(25(OH)D); the major circulating form of vitamin D in human body.1,6,23,34 The DBP then 
transports 25(OH)D to the kidney through blood system.23 Once in the kidney, 25(OH)D 
is hydroxylated on the position of carbon 1 (C-1) by 25(OH)D 1α-hydroxylase (1-OHase) 
to form 1,25-dihydroxyvitamin D (1,25(OH)2D); the active form of vitamin D.2,7,22,23,26 
The hormone form of vitamin D, 1,25(OH)2D, is then transported to various target tissues 
and organs.25,27,30,31 1,25(OH)2D regulates various body systems by binding to vitamin D 
receptors (VDR) located at the target cells.15,25,28,32 For example, calcium metabolism is 
regulated by the interaction of 1,25(OH)2D with bone, intestinal and renal VDRs. These 
interactions regulate bone mineral metabolism; improve intestinal absorption of calcium; 
and improve resorption of calcium in the distal renal tubules, respectively.15,23,28 
1,25(OH)2D will ultimately be catabolized in the kidney, hydroxylated by 1,25-
dihydroxyvitamin D3 24-hydroxylase (24-OHase)  to form the inactive form of vitamin D 
(calcitroic acid), which is then excreted in the bile.31  
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Figure 2: Vitamin D3 Synthesis/ Metabolism.23 
 
 
Vitamin D deficiency 
 Vitamin D deficiency is a worldwide public health problem in all age groups, with 
a roughly 40% prevalence and increasing every year, even in developed countries (where 
vitamin D fortification and supplement is available and affordable).6,7,35 Daily diet only 
contributes to a small portion of vitamin D that is needed; therefore, the major source of 
vitamin D stems from sufficient sunlight exposure.1,6,9,14,36 In the 17th century, during the 
industrial revolution, the deformed bone disease, rickets, dramatically increased in 
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children, and the major cause is lack of sun exposure.1,15,37 High and close buildings, 
increased indoor activities, and coal burning air pollution blocked the sunlight access.1 A 
century later, vitamin D fortification and supplementation were developed and 
implemented to improve vitamin D access and bone health; an alternative solution to the 
effects of insufficient sunlight to improve vitamin D status.1,15,36,38  
However, vitamin D deficiency remains a public health issue for many 
populations, particularly for those who have inadequate sun exposure or no food 
fortification. For example, individuals who live northern of 33°N, do not have adequate 
exposure to solar UVB radiation for vitamin D synthesis for at least 3-4 months of the 
year.1 The elderly population in particular have less vitamin D3 synthesized than young 
because aging decreases the amount of 7-DHC, and they tend to have less outdoor 
activities.5,36,39–41 Additionally, it is important to recognize that many variables in 
addition to sunlight exposure affect serum vitamin D status including skin tone, aging, 
vitamin D intake, digestive function, obesity, body composition, physical activities and 
life-style.3,15,35,41,42 
 The concentration of serum 25(OH)D is a common useful indicator of vitamin D 
status because it has a longer metabolic half-life than other metabolites of vitamin D.37,43 
Also, the concentration of serum 25(OH)D is 1000-fold higher than the concentration of 
the active form 1,25(OH)2D.44 Although there are many different definitions of vitamin D 
deficiency described by journals or institutes, most vitamin D scientists use the definition 
of a serum 25(OH)D level below 20 ng/ml (50 nmol/liter) as vitamin D deficiency; a 
serum 25(OH)D of 21–29 ng/ml (52.5–72.5 nmol/liter) as vitamin D insufficiency; and a 
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serum 25(OH)D above 30 ng/ml (75 nmol/liter) as vitamin D sufficiency.9,32,37,45 Many 
clinical research studies have reported serum 25(OH)D levels below 20 ng/ml as being 
associated with decreasing calcium metabolism and many other chronic 
disease.1,6,7,9,14,21,27,33,39 
  Vitamin D deficiency and insufficiency is considered a heavy social burden in 
both developed and developing counties.37–40 Research has shown that serum vitamin D 
level less than 20 ng/ml would reduce half of the dietary absorption of calcium and 
phosphorus; is associated with immune function issues, and many chronic diseases, such 
as colorectal cancer, breast cancer, cardiovascular event, type 2 diabetes, fractures, 
influenza and mental health.2,22,27,37,42,45 Furthermore, numerous government agencies 
recommend minimizing exposure to sun for fear of its association to non-melanoma skin 
cancer. However, these same governmental agencies disregard the important public 
health issues associated with low vitamin D levels.7,46 Since a modernized life-style does 
not assure vitamin D sufficiency, it is important to be aware of this oftentimes overlooked 
public health problem.  
 
Table 1. Terminologies Describing Vitamin D status1,15,32  
Status Serum 25(OH)D level 
Deficiency ≤ 20 ng/ml (50 nmol/liter) 
Insufficiency  21–29 ng/ml (52.5–72.5 nmol/liter) 
Sufficiency ≥ 30 ng/ml (75 nmol/liter) 
 (1ng/ml = 2.5 nmol/Liter) 
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Seasonal changes and serum 25(OH)D level 
 Research has consistently shown the role and importance of vitamin D in seasonal 
infectious disease, influenza, fractures, cancer and respiratory infection.6,8,42,47–51 
Cutaneous photosynthesis from exposure to sunlight UVB is the major source by which 
the daily requirement for vitamin D is achieved, even in those countries with vitamin D 
fortified policies.  
 At high solar zenith angles, sunlight UVB radiation must travel longer distances 
to reach the earth’s surface, thereby increasing the probability of absorption by the 
stratospheric ozone layer.1,19 Thus, the longer the distance that sunlight UVB radiation  
must travel to reach the earth, the less vitamin D is available for production in the skin. In 
addition, solar zenith angles are affected by latitude and seasons. Holick et.al reported 
that people who live above 33°N and 33°S latitude produce little vitamin D from sun 
exposure during the winter months.1 This phenomenon is even more significant in the 
higher latitude areas such as Edmonton, Canada (52.5°N) or Berlin, Germany (52°N), 
where people have very little vitamin D synthesized from sunlight for nearly 6 
months.29,52  
A number of studies have also shown that low serum 25(OH)D levels are 
associated with seasonal changes. Klingberg et al., using cohort data from 540 adults 
living in Gothenburg, Sweden (57°N) concluded that serum 25(OH)D levels were 
strongly associated with seasonal changes.34 Sullivan et al. followed seasonal variance 
serum 25(OH)D levels in 23 adolescent girls living in Bangor, Maine (44°N) for 3 years. 
They found that 48% of the subjects exhibited vitamin D insufficiency during the winter 
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compare to 17% of subjects who exhibited vitamin D insufficiency during the summer.53 
Similarly, Kroll et al., using a cross-sectional study of serum 25(OH)D levels in 3.8 
million adults living in the U.S found that seasonal variation was observed in all genders 
and for all latitudes.54 Even in the low latitude area, such as Miami, Florida (25°N), with 
sunny and warm weather throughout the year, it was found by Levis et al. that serum 
25(OH)D levels in 212 adult participants increased 14% in the summer compared to 
winter months.17  
Alternatively, some studies offer contrasting results. Heidari et al. examined 
cross-sectional data from 696 participants living in Babol, Iran (36°N), and found no 
significant difference in serum 25(OH)D levels in subjects between the summer and 
winter months.55 Moreover, a study conducted in Chiba, Japan (35°N) found that outdoor 
female athletes had similar serum 25(OH)D level in the summer and winter.56 Although 
these studies showed no significant seasonal difference in serum 25(OH)D averages, they 
have admitted the possible influence caused by potential confounders such as the 
environment of physical activity, sun exposure time, vitamin D intake and health status. 
57 This means that, despite the fact that several studies discovered opposing results, 
seasonal changes (solar zenith angles changes) still play a role on influence serum 25-
hydroxyvitamin D levels. 
 Serum 25(OH)D levels are also regulated by other seasonal factors that impact 
lifestyle and daily physical activity. For example, hot or cold temperatures, snow, rain, 
wind or extreme weather may decrease the inclination to participate in outdoor activities, 
whether it be mowing the grass, having a barbeque, swimming in the pool, or simply 
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taking a walk.58,59 In fact, numerous studies support this pattern whereby individuals tend 
to participate in more outdoor physical activities during the summer, and tend to be more 
sedentary time during the winter months.31, 60–62 Despite the fact that evidence shows a 
strong association between winter, low temperature, and their impact on seasonal serum 
25(OH)D changes, a study conducted in Saudi Arabia showed surprising results during 
summer months; significant lower serum 25(OH)D level during the summer. 57 This 
unexpected finding may be explained by some reasons. The people in Saudi Arabia 
intentionally avoid sun exposure during day time in the summer, especially from late 
morning to early afternoon, the time that enough solar UVB reach to earth’s surface for 
vitamin D production. In addition, the customary clothing and robe, which covers the 
entire body to prevent the scorching of sunlight during the summer season.17,57 Lastly, 
there are a few epidemiological studies which show that in the winter months the risk of 
obesity and increased BMIs are associated with low serum 25(OH)D levels.19,63–65 The 
people who had high BMI (great body volume) would had more volumetric dilution of 
serum vitamin D than those who had low BMI.66 Thus, high BMI and obesity were 
considered inversely associated with serum vitamin D status. Overall, seasonal factors 
impact the life-style and sunlight UVB exposure thereby affecting serum 25(OH)D 
levels.  
 
Aging and vitamin D  
 Aging and vitamin D deficiency are considered highly related, specifically that 
aging decreases vitamin D synthesis in skin.1,19,67,68 There is an inversely relationship 
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between the concentration of 7-DHC in the epidermis cells and aging process. The age 
associated decrease of epidermal 7-DHC results in the need for more sun exposure so as 
to ensure adequate amounts of vitamin D.67 Increase area of exposure to sunlight is a 
sensible way to control risk of sunburn than increasing time of exposure. Holick et al. 
observed there is 50% decrease in the production of pre-vitamin D in elderly subjects 
(age 88) compared to young adults (age 21).1,5,67 In addition, skin becomes thinner during 
the aging process, which may contribute to the decrease in vitamin D production in 
epidermal cells.19,67 Thus, the benefit of sunlight exposure in the elderly population is not 
as significant as young population. Lastly, some study reported that elderly populations 
spend less time in outdoor activities and are more inactive, which may reduce their sun 
exposure and thereby lower their cutaneous vitamin D synthesis.67,69  
 Several clinical studies which examined elderly populations (age 65 and older) 
demonstrated that low 25(OH)D levels were associated with an increased risk of low 
muscle strength, cognitive impairment, falls, fractures, autoimmune diseases, 
cardiovascular events, type 2 diabetes and cancers.70–74 Therefore, elderly adults (age 
above 65) as a population at risk for vitamin D deficiency, should be encouraged to take 
vitamin D supplements to maintain normal levels of serum 25(OH)D.68 
 
Vitamin D supplementation  
 Many publications suggest that adults 65 years and older should take at least 800 
IU/d (International Unit per day, 1 IU = 0.025 µg) of vitamin D supplements in order to 
maintain maximal muscle function and bone health.9,71,72 However, it may require more 
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than 1500 IU/d of vitamin D supplements to increase the serum 25(OH)D levels above 
the desired 30ng/ml.9,68,75 Some studies also indicate that the administration of high doses 
of vitamin D either monthly, quarterly or yearly can be effective for maintaining serum 
vitamin D status.72,76 However, a meta-analysis indicated that intermittent high dose of 
vitamin D do not have a beneficial effect as the normal daily dose of vitamin D.77 An 
annual single high dose of vitamin D may not provide adequate concentrations in the 
blood over the whole year and potentially increase fall and fracture risk.78 People with 
long-term inflammatory bowel disease or malabsorption and those have intestinal gastric 
bypass surgery may need more vitamin D supplement to maintain their vitamin D 
status.6,79 
 The common vitamin D supplement can be found in multivitamin supplements, 
multi-mineral formulations and in single tablet formulation ranging in a variety of doses.6 
Multivitamin tablets with 400 IU of vitamin D are generally found, however, some 
pharmaceutical companies, over the past year, have launched new products which contain 
600 to 1000 IU of Vitamin D.6,77,80 In addition, vitamin D supplementation tablets 
without other nutrients are available in vitamin D doses of 400, 1,000, 2,000 also 5,000 
international units at pharmacies and supermarkets.76 Therefore, vitamin D 
supplementation is a practical and affordable strategy to preserve bone health, immune 
function, and prevent diseases and conditions such as osteoporosis, rickets and fractures. 
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Toxicity of vitamin D 
 Vitamin D toxicity, also called hypervitaminosis D, is rare and is usually caused 
by the ingestion of extremely high doses of vitamin D supplements over a long-term 
period of time.1,42 In addition, some cases of hypervitaminosis D have been caused by the 
accidental ingestion, self-medication, or malpractice of vitamin D.81–83 The United States 
Institute of Medicine reported that for both male and female adults the ingestion of 4,000 
IU/day (100 µg) of Vitamin D is a tolerable upper intake level (UL), suggesting that this 
dose level is without risk of adverse effect for most people.2,79 The endocrine society also 
recommended that 10,000 IU/day might be needed for adults 19 year and older to correct 
vitamin D deficiency.9 In addition, Ekwaru et al. observed that 20,000 IU/day is still safe 
among healthy adults.84 However, an increase of serum 25(OH)D levels over 150ng/ml, 
also called vitamin D intoxication, is considered harmful as it is associated with 
hypercalcemia, hypercalciuria, anorexia, weight loss, polyuria, heart arrhythmias, renal 
and cardiovascular damage.1,2,79 
 Vitamin D intoxication will never be caused by sunlight exposure because 
epidermal pre-vitamin D3 and vitamin D3 are converted into many non-active 
photoproducts when exposed to sunlight. Sun exposure does not only process vitamin D 
photosynthesis, but it also destroys excess vitamin D and pre-vitamin D.1,85 Therefore, 
appropriate sunlight exposure is recommended as the most optimal way to prevent 
vitamin D deficiency.86 
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Study Rationale 
 The effect of seasonal changes on serum vitamin D levels among the elderly (age 
65 years and older) community-dwelling population has not been well evaluated. There is 
substantial evidence that serum 25(OH)D levels are affected by seasonal changes with 
peaks in the late-summer and nadirs in the late-winter. A serum 25(OH)D ≤ 20 ng/ml (50 
nmol/L) is considered vitamin D deficient, which is a global public health issue as there 
is a 40% worldwide prevalence which is increasing every year.  
Vitamin D deficiency is highly associated with the risk of immune system 
malfunction; cancers including colorectal and breast cancer; cardiovascular events; type 2 
diabetes; fractures; seasonal influenza; mental disorders, and many other chronic 
diseases. Thus, the public health implications of this deficiency is incredibly relevant and 
important. 
The population most at risk for vitamin D deficiency are the elderly (age above 
65) because aging decreases the ability of the body to synthesize vitamin D in the skin. 
For this reason, the effect of seasonal changes on vitamin D synthesis have important 
public health implications for this population. Consequently, this study will examine the 
effect of seasonal changes on serum vitamin D status in individuals 68 years and older. 
Also, the results of this study hope to guide physicians in addressing vitamin D 
deficiency in this vulnerable population, improving upon the primary care for elderly 
adults.  
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Primary Study Question 
 Are seasonal variations associated with vitamin D status among healthy 
individuals 68 years and older who resided in Boston, Massachusetts and Stockholm, 
Sweden? 
 
Primary Objective  
 The primary objective was to investigate the impact of seasonal changes (winter/ 
summer) and serum 25(OH)D levels among community-dwelling elders in the Boston, 
Massachusetts and Stockholm, Sweden. 
 
Secondary Objective  
 The secondary objective was to investigate the effect modification of 
geographical factors (city/ latitude) on seasonal serum 25(OH)D level changes. 
 To compare the results of cross-sectional and longitudinal cohort design in the 
same study population.  
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METHODS  
 
Study Design 
 This was a combination of a cross-sectional and longitudinal cohort study to 
investigate the seasonal serum 25(OH)D level changes between inter-individual 
differences and intra-individual by analyzing existing data obtained from the VIVE2 
database (The Vitality, Independence, and Vigor in the Elderly 2 Study) 
(ClinicalTrials.gov Identifier: NCT01542892). The database was de-identified and 
approved by the Tufts Health Sciences Campus Institutional Review Board. All 
associated variables (serum vitamin D 25(OH)D, country, BMI, age, enrollment date, 
subject ID, sex and visit time) were extracted from the VIVE2 dataset, collected between 
2012 and 2014.  
 
Overview of VIVE2 Study 
 The VIVE2 study was a multi-center, randomized (parallel assignment), double 
blinded, interventional trial, conducted in the United States and Sweden. In the study, 149 
participants were randomized to receive a daily dose of vitamin D and protein nutritional 
supplement (NESTLÉ® “Senior II”), or a placebo for 6 months. The nutritional 
supplement was a 150 kcal small volume unit (4 fl.oz., 119 ml) composed of whey 
protein (20g) and vitamin D (800 IU). The nutritional supplement was compared to a 
placebo beverage consisting of 30 kcal in a volume of 119 ml. All participants were 
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required to join a 3 times per week multi-model physical activity training program which 
included strength training, stretching and balance exercises. The study outcomes were 
measured at baseline, 3-Months and 6-Months.  
 The details of inclusion and exclusion criteria for VIVE2 study are described in 
Appendix I. In summary, subjects were community-dwelling elderly adults above the age 
of 68 and willing to be randomized and participate in all study interventions. Each subject 
had low vitamin D intake (≤ 800 IU/ day) and were generally in good health without 
recent cardiovascular events, liver malfunction, diabetes, recent surgery, renal 
malfunction and cancers. In addition, all subjects admitted to a lack of participation in 
regular physical activity and were at a high risk for mobility limitations based on the 
Short Physical Performance Battery (SPPB, score ≤ 9). 
 
Biological Samples 
 In the VIVE2 study blood draws were taken at baseline, Month 3, and Month 6 to 
measure standard laboratory analyses, blood lipids and hematology, acute phase proteins, 
and circulating cytokines. Serum 25(OH)D levels were measured by DiaSorin RIA kit 
(DiaSorin, Stillwater, MN, USA), which was the first FDA approved, and widely used 
vitamin test kit for clinical diagnosis.87 
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Study Subjects for This Study 
 This study was based on the VIVE2 study database and the inclusion and 
exclusion criteria included the following.  
Inclusion criteria, participants: 
• Had participated in the VIVE2 study 
• Had followed the VIVE2 study inclusion/ exclusion criteria 
• Were 68 years of age or older 
• Were enrolled during the summer months (July, August and September) 
• Were enrolled during the winter months (January, February and March) 
 
Exclusion criteria, participants: 
• Were	enrolled	during	the	spring	months	(April,	May	and	June) 
• Were	enrolled	during	the	autumn	months	(October,	November	and	December) 
• Withdrew from the VIVE2 study 
• Were assigned to the interventional group (i.e. given extra liquid nutritional 
supplement including whey protein (20 g), and vitamin D (800 IU)) in the VIVE 2 
study 
 	 The above criteria were adapted for the cross-sectional aspect so as to investigate 
the inter-individual seasonal variation of serum 25(OH)D. For the longitudinal 
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assessment, the same criteria were adapted and all participants who were assigned to the 
interventional group or had missing value were excluded. 
Statistical Analysis 
 The baseline information was described using means, ranges and standard 
deviations to characterize continuous variables (including: age, BMI, serum vitamin D 
and (25(OH) D) levels). Percentages and frequencies were used to characterize 
categorical variables (including: sex, country, and season). An exploratory analysis was 
used to compare the baseline results between two seasons (summer/ winter). Student t-
test were used for continuous variables and chi-squared test were used for categorical 
variables.  
 
Intra-individual: 
 The primary objective analysis compared the effect of seasonal changes on the 
serum 25(OH)D levels. The study subjects were divided into two cohorts, summer and 
winter, in order to compare the difference in serum 25(OH) D levels. A mono-variable 
analysis was conducted by the Student t-test, looking at the different means of serum 
25(OH)D level between two cohorts. Relative risk and 95% confidence intervals were 
used to compare the prevalence of vitamin D deficiency between the two seasons (i.e. – 
summer and winter). The additional variables, such as age and BMI, were controlled for 
in the multi-variables analysis. The secondary objective was assessed by testing the effect 
modification of study sites in the serum 25 (OH)D levels for both seasons.  
 
	21 
Inter-individual: 
 The data were extracted from the VIVE2 longitudinal database. Only the data 
from subjects in the control group, who were enrolled during the summer and winter, 
were included in this analysis. All missing values were removed. The primary objective, 
the difference of inter-individual serum 25(OH)D levels between the summer and winter 
months, were analyzed and the Student t-test was used to examine the primary objective. 
The secondary objective was assessed by testing the effect modification of serum 
25(OH)D levels between countries. 
 
 A p < 0.05 was considered as statistically significant, p < 0.2 was considered as 
confounders. All statistical analysis was performed by R for Mac (R 3.3.2), Microsoft® 
Excel for mac 2016. 
 
Figure 3:  Study Flow Chart. 
  
	22 
RESULTS 
 
Demographic Information  
 The overall baseline characteristics for the 71 subjects who met the inclusion and 
exclusion criteria are described in Table 2. In the current study, thirty-eight (53.5%) 
subjects were from Boston and thirty-three (46.5%) were from Stockholm. The age of the 
study subjects ranged from 68.7–89 (mean ± SD = 77.4 ± 5), with 53.5% and 46.5% of 
the subjects categorized as male and female, respectively. The mean serum 25(OH)D 
level was 17.4 ± 6.1 ng/ml with 70.4% subjects who met the definition of vitamin D 
deficiency (serum 25(OH)D ≤ 20 ng/ml). The mean baseline BMI was 28.1 ± 3.7 kg/m2; 
most participants (73%) met the national definition of overweight (25 kg/m2 ≤ BMI ≤ 30 
kg/m2).  
 
Table 2. Baseline Characteristics  
Characteristics Value 
Total [N] 71 
Age [yr (mean ± SD, range)] 77.4 ± 5, 68.7–89.1 
Serum 25(OH)D levels [ng/ml (mean ± SD, range)] 17.4 ± 6.1, 7–37 
Vitamin D deficiency [N, (%)] 50 (70.4) 
BMI [kg/m2 (mean ± SD, range)] 28.1 ± 3.7, 21.1–36.4 
Male [N, (%)] 38 (53.5) 
Female [N, (%)] 33 (46.5) 
Boston, MA site [N, (%)] 38 (53.5) 
Stockholm, Sweden site [N, (%)] 33 (46.5) 
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 The distribution of the baseline characteristics is shown in Figure 4. The top 
diagram shows the distribution of age in this study, which is not normally distributed; 
instead, it was skewed right, meaning that more subjects are on the left side of the 
histogram than the right side. The left diagram at the bottom presents the distribution of 
serum 25(OH)D levels, which is considered roughly normally distributed, and most 
subjects met the criteria of vitamin D deficiency (< 20 mg/ml). Similar to serum 
25(OH)D level, BMI is also considered roughly normally distributed; few subjects were 
of normal weight (18.5 kg/m2 ≤ BMI ≤ 25 kg/m2), while most subjects were overweight.  
 
Figure 4: Distribution of the Baseline Characteristics. 
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Inter-individual Analysis (cross-sectional) 	
 The Table 3 shows the comparison of the mono-variables between the summer 
and winter, including serum 25(OH)D level, vitamin D deficiency, age, BMI, sex and 
study site. The serum 25(OH)D level was significantly different with a p-value 0.034 
between the summer and winter with a mean (± SD) of 19.8 ± 6.3 and 16.4 ± 5.7, 
respectively. The serum 25(OH)D of participants who were enrolled during the summer 
had an average 3.4 ng/ml higher than those who were enrolled during the winter. The 
prevalence of vitamin D deficiency was significantly different with 45.5% participants in 
the summer group who were found vitamin D deficient, while 81.6% were deficient in 
the winter. Both the summer and winter groups showed a high prevalence of vitamin D 
deficiency compared to the national prevalence (41%).41 There was no significant 
difference in age, BMI, sex and study sites between the summer and winter.  
 
Table 3. Serum 25(OH)D level, Vitamin D deficiency, Age, BMI, Sex and Site of the 
Summer and Winter 
 Summer (n = 22) Winter (n = 49) p-Value 
25(OH)D [ng/ml (mean ± 
SD)]  
19.8 ± 6.3 16.4 ± 5.7 0.034* 
Vitamin D deficiency [no. 
(%)] 
10 (45.5) 40 (81.6) 0.005** 
Age [yr (mean ± SD)] 76.4 ± 4.8 77.8 ± 5 0.29 
BMI, [kg/m2 (mean ± SD)] 27.7 ± 4.5 28.3 ± 3.4 0.63 
Sex [Male (%)] 9 (40.9) 29 (59.2) 0.24 
Site [Boston (%)] 15 (68.2) 23 (46.9) 0.16 
* p-Value < 0.05 
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** p-Value < 0.01 
 
 The general linear models were adapted to investigate the association between 
each variable and serum 25(OH)D levels. The unadjusted model, Table 4, shows that 
participants in the summer group had a mean serum 25(OH)D level of 19.8 ng/ml, while 
participants in the winter group had an average serum 25(OH)D level of 3.4 ng/ml lower. 
This result was statistically significant with a p-value of 0.025. There were no statistically 
significant results when comparing serum 25(OH)D level by age, BMI, and sex, which 
were described in Tables 5, 6 and 7. These variables were not taken into multi-variable 
model as confounders. However, the result of unadjusted model in Table 8, comparing 
serum 25(OH)D level by study country, had a p-value 0.155; a p-value less than 0.2 was 
considered as a confounder or effect modification. Table 9 presents that serum 25(OH)D 
level difference between the summer and winter after controlling for study country; the 
result was still significant with p-value less than 0.01. In addition, the subjects who were 
in USA site would have an average 2.8 ng/ml lower; statistically significant at a p-value 
0.049. 
 
Table 4. Unadjusted Model Comparing 25(OH)D Between the Summer and Winter   
Serum 25(OH)D level (ng/ml) 
 Estimate Std. Error p-Value 
Intercepta 19.8 1.3 < 0.001 
Winter -3.4 1.5 0.025* 
a represent for the average serum 25(OH)D level for subjects in the summer group 
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Table 5. Unadjusted Model Comparing 25(OH)D by Age 
Serum 25(OH)D level (ng/ml) 
 Estimate Std. Error p-Value 
Intercepta 17.8 11.4 0.094 
Age -0.03 0.14 0.86 
a represent for the average serum 25(OH)D level for age 65 
 
Table 6. Unadjusted Model Comparing 25(OH)D by BMI   
Serum 25(OH)D level (ng/ml) 
 Estimate Std. Error p-Value 
Intercepta 15.8 5.5 0.04 
BMI 0.2 0.2 0.28 
a represent for the average serum 25(OH)D level for BMI 20 
 
Table 7. Unadjusted Model Comparing 25(OH)D by Sex   
Serum 25(OH)D level (ng/ml) 
 Estimate Std. Error p-Value 
Intercepta 18.2 1.1 < 0.001 
Male -1.5 1.4 0.3 
a represent for the average serum 25(OH)D level for female subjects 
 
Table 8. Unadjusted Model Comparing 25(OH)D by Site 
Serum 25(OH)D level (ng/ml) 
 Estimate Std. Error p-Value 
Intercepta 18.5 1.1 < 0.001 
USA -2.06 1.4 0.155b 
a represent for the average serum 25(OH)D level for subjects in Stockholm, Sweden 
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b p-Value < 0.2, consider as confounding or effect modification 
 
 
Table 9. Adjusted Model Comparing 25(OH)D Between the Summer and Winter   
Serum 25(OH)D level (ng/ml) 
 Estimate Std. Error p-Value 
Intercepta 21.7 1.6 < 0.001 
Winter -4.1 1.5 0.009** 
USA -2.8 1.4 0.049* 
a represent for the average serum 25(OH)D level for subjects in the summer group 
* p-Value < 0.05 
** p-Value < 0.01 
 
 Effect modification of country was investigated using a stratified analysis, as 
described in Table 10. There were 38 and 33 subjects in the USA and Sweden sites, 
respectively. The subjects in the USA site had an average 18.3 ng/ml of serum 25(OH)D 
level during the summer compared to the subjects in the Sweden site with an average 
23.1 ng/ml. The Sweden group had a higher serum 25(OH)D level than the USA group 
during the summer. In the USA group, subjects were estimated to have 3 ng/ml lower in 
serum 25(OH)D levels during the winter, however the result was not statistically 
significant. On the other hand, the Sweden group was estimated to have an average 5.9 
ng/ml lower in serum 25(OH)D level during the winter, which was statistically 
significant with a p-value < 0.05. Additionally, the seasonal serum 25(OH)D changes 
were 3 ng/ml and 5.9 ng/ml in the USA site and the Sweden site, respectively. This result 
indicated that seasonal changes had a larger impaction on serum 25(OH)D level in the 
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Sweden site than the USA site. All stratified results were presented as box plots in Figure 
5. 
 
 
Table 10. Effect Modification of Country in Serum 25(OH)D level 
 USA (N= 38) Sweden (N= 33) 
 Estimate Std. Error p-Value Estimate Std. Error p-Value 
Intercepta 18.3 1.4 < 0.001 23.1 2.3 < 0.001 
winter -3 1.8 0.12 -5.9 2.6 0.029* 
a represent for the average serum 25(OH)D level (ng/ml) for subjects in the summer group 
* p-Value < 0.05 
 
 
 
 
 
 
 
Figure 5: Box plot of serum 25(OH)D in the summer and winter/ stratified by the 
study country (The values represent medians, interquartile and ranges). 
 
 During the summer, 45% (10/ 22) of subjects had serum 25(OH)D levels lower 
than 20 ng/ml (vitamin D deficiency), and 50% (11/ 22) had serum 25(OH)D levels 
between 20 ng/ml and 30 ng/ml (vitamin D insufficiency), compare with the winter, 
when 82% (40/ 49) had serum 25(OH)D lower than 20 ng/ml (vitamin D deficiency), and 
	29 
14% (7/ 49) had serum 25(OH)D levels between 20 ng/ml and 30 ng/ml (vitamin D 
insufficiency). The prevalence of vitamin D deficiency between summer and winter was 
statistically significant with a p-value 0.005 (Table 3 and Figure 5). In Table 11, the 
winter group was found to have higher risks of vitamin D deficiency with a relative risk 
1.8 (95% CI: 1.1 - 2.9), compared to the summer group. The results indicate that the 
winter group had 80% increased risk of vitamin D deficiency, a statistically significant 
results with a p-value less than 0.01.  
 
 
Figure 6: Pie Chart of Vitamin D Status in the Summer and Winter 
 
Table 11. RR and 95 CI of Vitamin D Deficiency 
 RRa (95%CIb) p-Value 
Summer - - 
Winter 1.8 (1.1 - 2.9) 0.002** 
** p-Value < 0.01 
a Relative Risk 
b 95% Confidence Interval 
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 The stratified analysis was used to investigate the effect modification of country, 
38 subjects in the USA site and 33 in the Sweden site (Figure 6). In the USA site, roughly 
46% (7/ 15) subjects were vitamin D deficient and 54% (8/ 15) were vitamin D 
insufficient during the summer, while 91% (21/ 23) were vitamin D deficient and 4% (1/ 
23) were vitamin D insufficient during the winter. At the Sweden site, approximately 
42% (3/ 7) were vitamin D deficient and 42% (3/ 7) were vitamin D insufficient during 
winter, while 72% (19/ 26) of subjects were vitamin D deficient and 24% (6/ 26) were 
vitamin D insufficient during summer. In Table 12, the USA group had double the risk of 
vitamin D deficiency in the winter, statistically significant with p < 0.01. The Sweden 
group showed no significant results (p > 0.05) with an increased risk of vitamin D 
deficiency by 70% in winter. 
 
Figure 7: Percentage Colum of Vitamin D Status in the Summer and Winter by 
Study Country 
 
Table 12. Effect Modification of Study Site in RR and 95 CI of Vitamin D Deficiency 
 Boston (N= 38) Stockholm (N= 33) 
 RR (95%CI) p-Value RR (95%CI) p-Value 
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Summer - - - - 
Winter 1.96 (1.1 – 3.5) 0.002** 1.7 (0.7 – 4.2) 0.13 
** p-Value < 0.01 
 
Intra-individual Analysis (longitudinal cohort) 
 In the intra-individual analysis, participants from baseline who were assigned to 
the control group and completed summer and winter assessments were included. All 
participants had completed the 6-month study visit. There were 30 subjects included in 
the study; 12 males and 18 females (Table 13). The average serum 25(OH)D level was 
19.4 ± 7 ng/ml during summer and 16.6 ± 6.9 ng/ml during winter with a non-significant 
result (p-value 0.13). Individual serum 25(OH)D levels are presented in Figure 7. 
Additionally, 47% subjects (14/ 30) were vitamin D deficient during summer, while 
73.3% subjects (22/ 30) were vitamin D deficient during the winter; a statistically 
significant difference (p-Value < 0.05).  
 
 
Table 13. Serum 25(OH)D levels and Vitamin D Deficiency for Intra-Individual 
During Summer and Winter 
Total = 30 (M: 12 / F: 18) Summer  Winter  p-Value 
25(OH)D [ng/ml (mean ± 
SD)]  
19.4 ± 7 16.6 ± 6.9 0.13 
Vitamin D deficiency [no. 
(%)] 
14 (46.7) 22 (73.3) 0.035* 
* p-Value < 0.05 
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Figure 8: Individual Serum 25(OH)D During Summer and Winter/ Box Plot for 
Individual Serum 25(OH)D by Season  
 
 In Table 14, the average 25(OH)D estimate for summer was 19.4 ng/ml; and there 
was a 2.8 ng/ml difference in 25(OH)D levels between summer and winter, which was 
not significant with a p-value 0.13. Table 15 and Figure 7 shows the effect modification 
of country with respect to seasonal serum 25(OH)D levels. The average 25(OH)D levels 
for summer were 19.41 ng/ml and 19.39 ng/ml serum for the USA and Sweden groups, 
respectively. The Sweden group had a larger seasonal serum 25(OH)D difference than 
the USA group, 3.77 ng/ml and 2 ng/ml, respectively. However, the seasonal serum 
25(OH)D differences within individuals for both countries was not statistically 
significant.  
 
 
	33 
Table 14. General Model for Comparing Individual Serum 25(OH)D in Summer 
and Winter 
Serum 25(OH)D level (ng/ml) 
 Estimate Std. Error p-Value 
Intercepta 19.4 1.26 < 0.001 
Winter -2.8 1.79 0.13 
a represent for the average individual serum 25(OH)D level (ng/ml) for cohort in summer 
 
Table 15. Effect Modification of Study Sites in Individual Serum 25(OH)D level 
 USA (N= 17) Sweden (N= 13) 
 Estimate Std. Error p-Value Estimate Std. Error p-Value 
Intercepta 19.41   1.91 < 0.001 19.39 1.58 < 0.001 
winter -2 2.7 0.46 -3.77 2.24 0.11 
a represent for the average individual serum 25(OH)D level (ng/ml) for cohort in summer  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Stratified Individual Serum 25(OH)D During Summer and Winter (left 
side)/ Stratified Box Plot for Individual Serum 25(OH)D by Season (right side) 
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 The individual vitamin D deficiency is presented in Table 16 as percentages and 
is compared by season using relative risks and 95% confidence intervals. During the 
summer, 46.7% subjects experienced 25(OH)D levels ≤ 20 ng/ml, which met the 
definition of vitamin D deficiency. Further, 73.3% of subjects were found to be vitamin 
D deficient during the winter. The subject cohort had a relative risk of 1.57 with 95%CI 
(1.01 – 2.44), indicating these subjects had a 57% increased risk of vitamin D deficiency 
during the winter. The test result was statistical significant with a p-value < 0.05.  
 After stratification, the effect modification of county is shown in Table 17. The 
proportion of vitamin D deficiency per site was 47% and 70.6%, and, 46.2% and 76.9% 
in the winter and summer for the USA and Sweden sites, respectively. Subjects at USA 
site experienced a relative risk 1.49 and 95%CI (0.83 – 2.7) for vitamin D deficiency 
during winter, implying that these subjects experienced a 49% increased risk of vitamin 
D deficiency during winter. At the Sweden site, subjects experienced a 67% increased 
risk for vitamin D deficiency with 95%CI (0.86 - 3.23). However, all test results were not 
significant.  
 
Table 16. RR and 95 CI of Individual Vitamin D Deficiency in the Cohort 
 VitD D (%)a RR (95%CI) p-Value 
Summer 46.7% - - 
Winter 73.3% 1.57 (1.01 – 2.44) 0.035* 
* p-Value < 0.05 
a Vitamin D deficiency in percentage 
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Table 17. Effect Modification of study sites in Individual RR and 95 CI of Vitamin 
D Deficiency 
 USA (N= 17) Sweden (N= 13) 
 VitDD 
(%)a 
RRb  
(95%CI) 
p-Value VitDD 
(%)a 
RRb 
(95%CI) 
p-Value 
Summer 47% - - 46.2% - - 
Winter 70.6% 1.49  
(0.83 – 2.7) 
0.16 76.9% 1.67  
(0.86 - 3.23) 
0.11 
a Vitamin D deficiency in percentage 
b Relative Risk 
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DISCUSSION 
 
 This is the first study designed to investigate both seasonal inter-individual and 
intra-individual variation in serum 25(OH)D levels among community-dwelling elders 
living in Boston, MA (42˚N) and Stockholm, Sweden (59˚N). Results demonstrated that 
community-dwelling elders residing in Boston, MA and Stockholm, Sweden were at a 
high risk of vitamin D deficiency regardless of the time of year examined (summer versus 
winter months) compared to the national prevalence of 41%. Overall, 70.4% (50/71) of 
study subjects exhibited a serum 25(OH)D level lower than 20 ng/ml, in other words, 
these subjects were vitamin D deficient. These results suggest that this population did not 
have adequate benefit from sunlight, which is the major source of vitamin D. It would be 
caused by limited sun exposure or aging process decreases vitamin D production. For 
example, it had been reported that the summer in Boston, vitamin D could be only 
produced between 10 AM to 3 PM, otherwise sunlight UVB is inadequate for vitamin D 
production.1 Moreover, despite that foods today are fortified with vitamin D and are 
readily available, and that vitamin D supplementation is affordable in the US and 
Sweden, overall the daily diet fails to support the elderly population reach optimal serum 
vitamin D status. Consequently, the elderly should be encouraged to include vitamin D 
supplementation, along with increased sun-exposure strategies in order to attain optimal 
vitamin D status.  
 Seasonal changes and latitude differences are major factors that influence the 
solar zenith angles; major predictors of Vitamin D status. In this study, serum 25(OH)D 
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levels were significantly lower among subjects in the winter versus the summer months, 
respectively, a finding consistent with previous studies.34,54,88 In this study, 45.5% (10/22) 
and 81.6% (40/49) of study subjects exhibited serum 25(OH)D levels lower than 20 
ng/ml during summer and winter months, respectively. Even though the sample size did 
not provide enough power to obtain significant test results after stratification by study 
sites, the trend of seasonal difference still could be observed (Appendix II). This 
phenomenon can be explained by the increased solar zenith angles during the winter 
months, which completely eliminate the amount of solar UVB reaches the earth’s surface. 
The implication of these findings for health care providers of the elderly is that 
recommendations regarding vitamin D supplementation must be offered regardless of the 
time of year these patients are seen. Actually, the Institute of Medicine Dietary 
Recommended Allowance of vitamin D for all age groups, indicated 400 IU for infant 
younger than 1-year age, 600 IU for children 1-year age to adults up to 70-year age and 
800 IU for adults older than 70-year age.2 The administration of vitamin D 
supplementation is especially important during the winter months because a high 
prevalence of seasonal muscle weakness, falls and fractures are observed, all of which are 
associated with low serum vitamin D status.89 
 In addition to time of year, latitude is also an important factor affecting vitamin D 
availability. Studies have shown that areas located in high latitudes experience greater 
seasonal day time and solar zenith angles variations in serum vitamin D status versus low 
latitude areas. Leary et al. investigated the influence of latitude on vitamin D among the 
medical students in Bradenton, Florida (27˚N) and Erie, Pennsylvania (42 ˚N) and found 
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that the subjects in Erie, Pennsylvania had higher prevalence of vitamin D deficiency 
than in Bradenton, Florida. Ladizesky et al. found that human skin exposed to sunlight in 
Ushuaia, Argentina (55˚S) could only produce half the amount of pre-vitamin D than 
subjects who resided in Buenos, Argentina (34˚N) during the summer months.90 
Conversely, this study showed that the subjects from Sweden exhibited higher average 
serum 25(OH)D than subjects in Boston in both the winter and summer months, even 
though the sample size did not provide enough power for a statistically significant result. 
The differences observed in this study might, in part, be explained by the skin 
pigmentation and life style of the study participants. Studies have shown that there is a 
lower prevalence of vitamin D deficiency in Scandinavia (Denmark, Norway, Sweden) 
due to lighter skin pigmentation, which have better formations of vitamin D in human 
skin. 91,92 In addition, high intake of oil-rich fish, vitamin D fortification food and 
supplementation, and sun-seeking behavior or highly frequency sunny holidays during 
winter months were all considered associated with good vitamin D status in 
Scandinavia.34,92  
 Moreover, the observation of the study found that the latitude did not play the 
most important role in influencing the serum vitamin D status. An epidemiological study 
conducted by Anna in Umea, Sweden (64˚N), showed that healthy young adults had an 
average serum 25(OH)D 26 ng/ml.92 Similarly, another epidemiological study conducted 
by Mitchell in Boston, MA (42˚N), showed that young healthy population had an average 
serum 25(OH)D 27 ng/ml.93 Conversely, a study conducted by Sabri in Ulaanbaatar, 
Monglia (47˚N) found an extremely low average serum 25(OH)D of 12 ng/ml among 
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young adults 94 These results suggest that there might be some factors which influence 
serum 25(OH)D levels beyond that of latitude, such as daily diet, supplementation intake, 
skin pigmentation, sun exposure frequency and life style. Unfortunately, these 
confounders were not collected into the current study, but should be examined in the 
future studies.  
 Many studies have reported a negative relationship between age and serum 
25(OH)D level, with aging being associated with an increased risk of vitamin D 
deficiency due to the low capacity of vitamin D synthesis in skin.1,29,38,55 However, this 
study failed to find this association, which might by effected by the narrow range of age 
of study subjects (69-89 years old). All study subjects who met the general definition of 
elderly (age >65) were included in this study, therefore this study was unable to find any 
association between serum 25(OH)D levels and age. In addition, obesity had been 
reported to be associated with vitamin D deficiency, which might be due to physical 
inactivity and the sequestration of serum vitamin D in adipose tissue. In a previous study, 
the obese group (BMI > 40kg/m2) had 40% lower serum 25(OH)D levels than the normal 
weight group (BMI < 25kg/m2).95 In this study, there was no significant relationship 
between BMI and serum 25(OH)D levels, however, this might be explained by the fact 
that most participants were overweight (25kg/m2  < BMI < 30kg/m2) and not obese. 
Therefore, the range of BMI was too narrow to observe this association.  
 In this study, the association between sex and serum 25(OH)D levels was not 
significant, with female subjects exhibiting slightly higher levels of  25(OH)D than male 
subjects. The relationship between sex and serum 25(OH)D levels is controversial. Some 
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previous study had indicated that males have significantly higher serum 25(OH)D levels 
than females.55,96 However, more recent studies conducted in the USA and Sweden show 
that there is no association between sex and serum 25(OH)D levels.92,93 This 
phenomenon might be explained by increasing sun-exposed activities among females, an 
increased trend of vitamin supplementation use, and changes in of types of clothing type. 
For example, women are more often tested and treated for vitamin D deficiency and 
osteoporosis than men.97 Moreover, sportswear for women has increased exposure rates 
from 38% to 53% since late 20th century, but men’s sportswear has remained almost the 
same with a exposure rate of 44%.98 Overall, both male and female elderly populations 
are facing equivalent risk of vitamin D deficiency in Stockholm, Sweden and Boston, 
MA. 
 
 The secondary objective of this study was to compare the results of cross-
sectional and longitudinal cohort study design. The seasonal serum 25(OH)D changes 
were significant in the cross-sectional study design (inter-individual) but not in the 
longitudinal cohort study design (intra-individual). There are some assumptions to 
explain the non-significant results. The informed consent process may be influenced by 
the subjects’ health literacy of vitamin D deficiency, therefore may attained a better 
awareness of vitamin D deficiency and thereby implemented strategies to maintain serum 
25(OH)D levels. Appendix III shows the serum 25(OH)D levels by stratification with 
enrolled season. The group enrolled during the summer exhibited average 25(OH)D 
levels of 16.3 ng/ml and 19.1 ng/ml, in the summer and winter months respectively. In 
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the group enrolled during the winter, the average 25(OH)D levels were 21 ng/ml and 15.7 
ng/ml, in the summer and winter months respectively. This result supports the assumption 
that the informed consent process may influence subject health literacy of vitamin D 
deficiency, which means subjects learned to obtain, process, and understand basic health 
information. When subjects were enrolled in the summer, they learned about the high risk 
of vitamin D deficiency in winter and thereafter they may have adapted vitamin D 
exposure or intake to supplement vitamin D status. On the other hand, those who were 
enrolled during winter months might learn about the benefit through sun exposure 
thereafter had a better optimal sunlight use. (Appendix III). In fact, the elderly population 
reported a high proportion of poor adherence, they may deliberately choose not to adhere 
to avoid the adverse effects of sun exposure.99 Therefore, in this 6-month period study, a 
cross-sectional study was considered more appropriate than the longitudinal design to 
measure seasonal serum vitamin D in order to mimic reality.  
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Limitations 
 The current study had many limitations. First, lacking the information regarding 
dietary intake of vitamin D and calcium among study subjects. Both the US and Sweden 
had vitamin D fortified food policies. For example, there was a mandatory vitamin D 
fortification in 3.8–5.0 µg/L for all milk in Sweden and an optional addition of vitamin D 
or calcium for milk in the USA.36,100 In a cohort study conducted with 212 adult subjects, 
which used a validated food frequency questionnaire to measure the vitamin D and 
calcium consumption over the study period.17 Higher level of vitamin D and calcium 
intake was associated with a better level of serum 25(OH)D. Therefore, daily vitamin D 
and calcium intake should be measured and controlled as confounders. 
 Second, the sample size did not support enough statistical power after 
stratification. In the intra-individual cohort study, there were only 13 subjects in the 
Sweden group after stratification, therefor this sample size did not provide enough power 
for the study thereby increasing the likelihood of creating a type II error. In addition, the 
study results was under estimated due to the small sample size. At least 16 subjects in 
each arm was necessary to maintain enough statistic power for the data analysis; 80% 
power to detect 11 ng/ml difference in serum 25(OH)D level.  Therefore, a small sample 
size is the limitation in this study.  
 Third, information about skin type or color of the study subjects was lacking, 
even though most participants were assumed to be Caucasian. People with white skin 
tone (skin type 2) can experience a 30-fold increase in serum vitamin D levels than those 
who have black skin tone (skin type 5) while exposed to the same amount of UVB 
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iiradiation.1 Therefore, skin pigmentation of subjects should be collected and controlled 
for as a confounder during data analysis. A longitudinal cohort study was designed to 
investigate the impact of season on Africa American and Caucasian children. Skin color 
was measured by Fitzpatrick scale, which is numerical classification for human skin color 
from type I (easy burn and no tan) to type VI (never burn and markedly tan).101 The 
results indicated that subjects with dark skin had a significantly lower level of serum 
25(OH)D than those who had light skin color during summer.   
 Lastly, there was no information about outdoor sun exposure and life-style for the 
study participants. Outdoor activity and tanning bed use would increase the exposure of 
UVB radiation, thereby affecting vitamin D synthesis. In particular, Americans, of whom 
like to travel around the world, including vacationing in tropical.102 Sunlight exposure 
time is one of the most important predictors for vitamin D status, sunlight exposure had 
been reported highly associated with optimal vitamin D status.7 Therefore, travel history, 
outdoor time and tanning bed use should be measured by questionnaires. Lastly, a few 
studies report that smoking might contribute to low serum 25(OH)D levels.103 Overall, 
UVB expose time, smoking and other life style factors should be collected and controlled 
for in the analysis.  
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Conclusion 
 This study investigated the impact of seasonal changes on serum 25(OH)D levels 
and found that elders in Boston and Stockholm had higher serum 25(OH)D levels in 
summer and lower in winter. While investigation the effect of latitude on serum 
25(OH)D, no association was found. Instead, many other confounders would affect serum 
25(OH)D level. Therefore, latitude is not the best predictor for serum 25(OH)D levels. In 
addition, there was no difference of serum 25(OH)D level between male and female, 
which indicated both male and female elders are facing high risk of vitamin D deficiency. 
Lastly, cross-sectional design is more appropriate to investigate seasonal serum 25(OH)D 
levels change than cohort design in such a short study period design. Despite the 
limitations in the study, the study results provided valuable knowledge regarding seasonal 
serum 25(OH)D changes in the elderly population living in Boston and Stockholm. The 
findings were hope to help clinician in interpreting vitamin D measurements for vitamin 
D deficiency diagnosis. 
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Future Study 
 Further study should be able to confirm the results of this study. An observational 
prospective cohort study to investigate the seasonal changes and serum 25(OH)D levels 
among elderly adults would be an appropriate study design for the future study. This 
study should be conduct in east coast such as Erie, Pennsylvania (42˚N) and Bradenton, 
Florida (27˚N). The study sites around east coast would minimize the deviation of culture 
and food differentiation. A larger sample size is needed to provide essential statistic 
power for the test results for stratum analysis, such as stratification of sex, latitude, and 
other covariates. All participants should be enrolled in the same month and followed for 
several years in order to reduce bias and deviations. The study subjects might change 
their life-style after the informed consent process, therefore all questionnaires should be 
adapted regularly to assess sun exposure time, outdoor activities, food intake, skin tone, 
vitamin D and calcium intake, life-style. A prospective cohort design including the above 
parameters would allow researchers to control for those potential confounders.  
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APPENDIX 
 
Appendix I. VIVE2 Study Inclusion/ Exclusion Criteria 
Inclusion Criteria For The VIVE2 Study 
 Male and Female aged 68 years or older 
 Community dwelling 
 SPPB Score ≤ 9 
 Willingness to be randomized and com to the laboratory for 6 months 
 Body Mass Index (BMI) ≤ 35 kg/m2 
 Mini-mental state examination (MMSE) ≥ 24 
 Serum 25(OH)D between 22.5 – 60 nmol/L 
 Having obtained his/her informed consent 
 Able to complete 400 M walk within 15 min 
Exclusion Criteria For The VIVE2 Study 
 Acute or terminal illness 
 Current regular use (more than 1 time per week) of high protein oral nutritional 
supplements (e.g. Nestlé Boost®, Exceed® etc...) 
 Current use of Vitamin D supplements (more than 800 IU per day) 
 Myocardial infarction in previous 6 months, symptomatic coronary artery disease, 
or congestive heart failure 
 Upper or lower extremity fracture in previous 6 months 
 Concentration of Hemoglobin < 10 g/dL 
 Estimated glomerular filtration rate (GFR) < 30 mL/min (severe decrease in GFR or 
kidney failure) 
 Uncontrolled hypertension ( > 150/90 mm Hg) 
 Neuromuscular diseases and drugs which affect neuromuscular function 
 Hormone replacement therapy 
 Insulin-dependent diabetes mellitus 
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 Uncontrolled non-insulin-depend diabetes (fasting glucose > 200 mg/Dl) 
 Milk protein allergy 
 Major surgery in the past 6 months (requiring general anesthesia) 
 Other significant co-morbid disease that would impair ability to participate in the 
exercise-based intervention, e.g. renal failure on hemodialysis, severe psychiatric 
disorder (e.g. bipolar, schizophrenia) 
 Excessive alcohol usage (> 14 drinks per week) 
 Participation in moderate intensity physical activity > 20 minutes/week 
 Inability to communicate due to severe, uncorrected hearing loss or speech disorder 
 Severe visual impairment (if it precludes completion of assessments and/or 
intervention) 
 Wheelchair bound 
 Severe progressive, degenerative neurological disease 
 Severe rheumatologic or orthopedic diseases, e.g., awaiting joint replacement, 
active inflammatory disease 
 Terminal illness with life expectancy less than 12 months, as determined by a 
physician 
 Cancer requiring treatment in the past three years, except for non-melanoma skin 
cancers or cancers that have clearly been cured or in the opinion of the investigator 
carry an excellent prognosis 
 Severe pulmonary disease, requiring either steroid pills, injections or the use of 
supplemental oxygen 
 Severe cardiac disease, including New York Heart Association (NYHA) Class III or 
IV congestive heart failure, clinically significant aortic stenosis, history of cardiac 
arrest, use of a cardiac defibrillator, or uncontrolled angina 
 Patient who cannot be expected to comply with treatment, as decided by the 
Principal Investigator and study physician 
 Conditions not specifically mentioned above may serve as criteria for exclusion at 
the discretion of the clinical site Principal Investigator and/or study physician 
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Appendix II. Power Curve of Sample Size 
 
 
 
 
 
 
 
 
 A Swedish cohort study investigated the inter-individual and intra-individual 
seasonal variations in serum 25(OH)D level with sample size 540. The average serum 
25(OH)D levels were found 19.2 ± 7.8 ng/ml in winter and 31.1 ± 10.9 in the summer. 
Therefore, the delta was considered 11.9 ng/ml and SD was considered 10.9 ng/ml. 
Under these assumptions a total of 16 subjects in each arm would be necessary to obtain 
80% power to detect a difference of 11.9 ng/ml. 
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Appendix III.  Intra-Individual Cohort 25(OH)D Level with Stratification of 
Enrollment Season 
Serum 25(OH)D level (ng/ml) 
 Summer Winter p-Value 
Total (n = 30) 19.4 ± 6.9 16.6 ±6.7 0.13 
Summer Enrolled (n = 8) 16.3 ± 6.3 19.1 ± 10 0.5 
Winter Enrolled (n = 22) 20.6 ± 6.8 15.7 ± 5.6 0.014* *	p	<0.05		
Total (n = 30) Subject Number 
Enrolled During Summer (n = 
8) 
U8, U10, U11, U12, U21, U22, S9, S10 
Enrolled During Winter (n = 22) U1, U2, U3, U4, U5, U15, U16, U17, U18, U19, 
U20 
S1, S3, S4, S6, S7, S8, S12, S14, S15, S16, S17 
 
 
 
 
 
 
 
 
 
 
(The values represent medians, interquartile and ranges) 
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Appendix IV. List of Outliers in Intra-Individual Study (High serum 25(OH)D in 
winter and Low serum 25(OH)D in summer) 
Subject 
No. 
Summer 
25(OH)D Level 
(ng/ml) 
Winter 
25(OH)D Level 
(ng/ml) 
Enrolling 
Season 
Sex Site 
U2 16 18 Winter M USA 
U5 11 15 Winter M USA 
U8 10 11 Summer M USA 
U10 7 9 Summer F USA 
U11 23 26 Summer F USA 
U12 21 37 Summer F USA 
U21 23 26 Summer F USA 
U22 16 25 Summer F USA 
S7 10 13 Winter F Sweden 
S8 17 25 Winter F Sweden 
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Appendix V. Wallace Rule of Nines (Estimate the Total Body Surface Area)104 
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Appendix VI. Fitzpatrick Scale105 
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